HEADER TRANSFERASE 18-MAR-09 3GNW TITLE HCV NS5B POLYMERASE IN COMPLEX WITH 1,5 BENZODIAZEPINE INHIBITOR 4C COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA-DIRECTED RNA POLYMERASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 2420-2989; COMPND 5 SYNONYM: HCV NS5B RNA POLYMERASE, NS5B, P68; COMPND 6 EC: 2.7.7.48; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS ISOLATE; SOURCE 3 ORGANISM_COMMON: HCV; SOURCE 4 ORGANISM_TAXID: 420174; SOURCE 5 STRAIN: HC-J4; SOURCE 6 GENE: NS5B; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET21B KEYWDS 1, 5-BENZODIAZEPINES, HEPATITIS C VIRUS, NS5B, POLYMERASE, SULFONE, KEYWDS 2 APOPTOSIS, ATP-BINDING, CAPSID PROTEIN, CELL MEMBRANE, ENDOPLASMIC KEYWDS 3 RETICULUM, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, HELICASE, KEYWDS 4 HOST-VIRUS INTERACTION, HYDROLASE, INTERFERON ANTIVIRAL SYSTEM KEYWDS 5 EVASION, LIPID DROPLET, LIPOPROTEIN, MEMBRANE, METAL-BINDING, KEYWDS 6 MITOCHONDRION, MULTIFUNCTIONAL ENZYME, NUCLEOTIDE-BINDING, KEYWDS 7 NUCLEOTIDYLTRANSFERASE, NUCLEUS, ONCOGENE, PALMITATE, KEYWDS 8 PHOSPHOPROTEIN, PROTEASE, RIBONUCLEOPROTEIN, RNA REPLICATION, RNA- KEYWDS 9 BINDING, RNA-DIRECTED RNA POLYMERASE, SECRETED, SERINE PROTEASE, KEYWDS 10 SH3-BINDING, THIOL PROTEASE, TRANSCRIPTION, TRANSCRIPTION KEYWDS 11 REGULATION, TRANSFERASE, TRANSMEMBRANE, VIRAL NUCLEOPROTEIN, VIRION EXPDTA X-RAY DIFFRACTION AUTHOR O.NYANGUILE,H.DE BONDT REVDAT 4 01-NOV-23 3GNW 1 REMARK SEQADV REVDAT 3 01-NOV-17 3GNW 1 REMARK REVDAT 2 13-JUL-11 3GNW 1 VERSN REVDAT 1 20-OCT-09 3GNW 0 JRNL AUTH K.VANDYCK,M.D.CUMMINGS,O.NYANGUILE,C.W.BOUTTON,S.VENDEVILLE, JRNL AUTH 2 D.MCGOWAN,B.DEVOGELAERE,K.AMSSOMS,S.LAST,K.ROMBAUTS,A.TAHRI, JRNL AUTH 3 P.LORY,L.HU,D.A.BEAUCHAMP,K.SIMMEN,P.RABOISSON JRNL TITL STRUCTURE-BASED DESIGN OF A BENZODIAZEPINE SCAFFOLD YIELDS A JRNL TITL 2 POTENT ALLOSTERIC INHIBITOR OF HEPATITIS C NS5B RNA JRNL TITL 3 POLYMERASE. JRNL REF J.MED.CHEM. V. 52 4099 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19507864 JRNL DOI 10.1021/JM9005548 REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 75.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 57548 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3028 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.39 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.45 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4184 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.04 REMARK 3 BIN R VALUE (WORKING SET) : 0.2110 REMARK 3 BIN FREE R VALUE SET COUNT : 220 REMARK 3 BIN FREE R VALUE : 0.2440 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8791 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 91 REMARK 3 SOLVENT ATOMS : 498 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.82000 REMARK 3 B22 (A**2) : -1.40000 REMARK 3 B33 (A**2) : -0.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.279 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.214 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.155 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.405 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9087 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 8301 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12348 ; 1.400 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): 19270 ; 0.816 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1126 ; 6.145 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 369 ;34.538 ;22.466 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1535 ;16.209 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 81 ;19.379 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1389 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 10016 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1879 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1950 ; 0.204 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 8456 ; 0.183 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4455 ; 0.177 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 5392 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 496 ; 0.146 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 14 ; 0.252 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 85 ; 0.237 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.229 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 7278 ; 1.214 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2261 ; 0.191 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 9115 ; 1.508 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4057 ; 2.267 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3233 ; 3.277 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3GNW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-MAR-09. REMARK 100 THE DEPOSITION ID IS D_1000052095. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91990 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61475 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 75.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.15800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.39 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.46 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.60700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: FROM 3CSO REMARK 200 STARTING MODEL: PDB ENTRY 3CSO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5-8% PEG 6000, 100MM MG-SALTS, PH REMARK 280 6.75, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 53.26700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.82850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.78650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 66.82850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 53.26700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.78650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -2 REMARK 465 ALA A -1 REMARK 465 SER A 0 REMARK 465 GLU A 150 REMARK 465 LYS A 151 REMARK 465 GLY A 152 REMARK 465 LEU A 564 REMARK 465 SER A 565 REMARK 465 ARG A 566 REMARK 465 ALA A 567 REMARK 465 ARG A 568 REMARK 465 PRO A 569 REMARK 465 ARG A 570 REMARK 465 LEU A 571 REMARK 465 GLU A 572 REMARK 465 HIS A 573 REMARK 465 HIS A 574 REMARK 465 HIS A 575 REMARK 465 HIS A 576 REMARK 465 HIS A 577 REMARK 465 HIS A 578 REMARK 465 MET B -2 REMARK 465 ALA B -1 REMARK 465 SER B 0 REMARK 465 GLU B 150 REMARK 465 LYS B 151 REMARK 465 GLY B 152 REMARK 465 GLU B 572 REMARK 465 HIS B 573 REMARK 465 HIS B 574 REMARK 465 HIS B 575 REMARK 465 HIS B 576 REMARK 465 HIS B 577 REMARK 465 HIS B 578 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 274 CB CYS A 274 SG -0.149 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 254 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG B 254 NE - CZ - NH2 ANGL. DEV. = -4.6 DEGREES REMARK 500 ARG B 280 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG B 280 NE - CZ - NH2 ANGL. DEV. = -4.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 15 166.96 162.16 REMARK 500 CYS A 223 71.24 41.75 REMARK 500 LEU A 260 -56.96 -129.06 REMARK 500 SER A 367 -9.63 67.74 REMARK 500 ILE A 424 -62.07 -100.04 REMARK 500 ILE B 23 88.14 -64.99 REMARK 500 GLU B 131 -45.68 -132.53 REMARK 500 LEU B 260 -59.15 -135.79 REMARK 500 SER B 347 64.41 64.57 REMARK 500 ALA B 348 58.15 -167.04 REMARK 500 SER B 367 -12.97 65.76 REMARK 500 ILE B 424 -64.57 -107.65 REMARK 500 SER B 476 60.11 60.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XNC A 579 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 580 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 581 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XNC B 579 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 580 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CSO RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 1,5-BENZODIAZEPINE 4A REMARK 900 RELATED ID: 3GNV RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 1,5-BENZODIAZEPINE 1B REMARK 900 RELATED ID: 3GOL RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 1,5 BENZODIAZEPINE INHIBITOR (R)-11D DBREF 3GNW A 1 570 UNP O92972 POLG_HCVJ4 2420 2989 DBREF 3GNW B 1 570 UNP O92972 POLG_HCVJ4 2420 2989 SEQADV 3GNW MET A -2 UNP O92972 EXPRESSION TAG SEQADV 3GNW ALA A -1 UNP O92972 EXPRESSION TAG SEQADV 3GNW SER A 0 UNP O92972 EXPRESSION TAG SEQADV 3GNW LEU A 571 UNP O92972 EXPRESSION TAG SEQADV 3GNW GLU A 572 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS A 573 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS A 574 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS A 575 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS A 576 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS A 577 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS A 578 UNP O92972 EXPRESSION TAG SEQADV 3GNW MET B -2 UNP O92972 EXPRESSION TAG SEQADV 3GNW ALA B -1 UNP O92972 EXPRESSION TAG SEQADV 3GNW SER B 0 UNP O92972 EXPRESSION TAG SEQADV 3GNW LEU B 571 UNP O92972 EXPRESSION TAG SEQADV 3GNW GLU B 572 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS B 573 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS B 574 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS B 575 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS B 576 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS B 577 UNP O92972 EXPRESSION TAG SEQADV 3GNW HIS B 578 UNP O92972 EXPRESSION TAG SEQRES 1 A 581 MET ALA SER SER MET SER TYR THR TRP THR GLY ALA LEU SEQRES 2 A 581 ILE THR PRO CYS ALA ALA GLU GLU SER LYS LEU PRO ILE SEQRES 3 A 581 ASN PRO LEU SER ASN SER LEU LEU ARG HIS HIS ASN MET SEQRES 4 A 581 VAL TYR ALA THR THR SER ARG SER ALA SER LEU ARG GLN SEQRES 5 A 581 LYS LYS VAL THR PHE ASP ARG LEU GLN VAL LEU ASP ASP SEQRES 6 A 581 HIS TYR ARG ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SEQRES 7 A 581 SER THR VAL LYS ALA LYS LEU LEU SER ILE GLU GLU ALA SEQRES 8 A 581 CYS LYS LEU THR PRO PRO HIS SER ALA LYS SER LYS PHE SEQRES 9 A 581 GLY TYR GLY ALA LYS ASP VAL ARG ASN LEU SER SER ARG SEQRES 10 A 581 ALA VAL ASN HIS ILE ARG SER VAL TRP GLU ASP LEU LEU SEQRES 11 A 581 GLU ASP THR GLU THR PRO ILE ASP THR THR ILE MET ALA SEQRES 12 A 581 LYS SER GLU VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY SEQRES 13 A 581 ARG LYS PRO ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY SEQRES 14 A 581 VAL ARG VAL CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SEQRES 15 A 581 SER THR LEU PRO GLN ALA VAL MET GLY SER SER TYR GLY SEQRES 16 A 581 PHE GLN TYR SER PRO LYS GLN ARG VAL GLU PHE LEU VAL SEQRES 17 A 581 ASN THR TRP LYS SER LYS LYS CYS PRO MET GLY PHE SER SEQRES 18 A 581 TYR ASP THR ARG CYS PHE ASP SER THR VAL THR GLU SER SEQRES 19 A 581 ASP ILE ARG VAL GLU GLU SER ILE TYR GLN CYS CYS ASP SEQRES 20 A 581 LEU ALA PRO GLU ALA ARG GLN ALA ILE ARG SER LEU THR SEQRES 21 A 581 GLU ARG LEU TYR ILE GLY GLY PRO LEU THR ASN SER LYS SEQRES 22 A 581 GLY GLN ASN CYS GLY TYR ARG ARG CYS ARG ALA SER GLY SEQRES 23 A 581 VAL LEU THR THR SER CYS GLY ASN THR LEU THR CYS TYR SEQRES 24 A 581 LEU LYS ALA THR ALA ALA CYS ARG ALA ALA LYS LEU GLN SEQRES 25 A 581 ASP CYS THR MET LEU VAL ASN GLY ASP ASP LEU VAL VAL SEQRES 26 A 581 ILE CYS GLU SER ALA GLY THR GLN GLU ASP ALA ALA ALA SEQRES 27 A 581 LEU ARG ALA PHE THR GLU ALA MET THR ARG TYR SER ALA SEQRES 28 A 581 PRO PRO GLY ASP PRO PRO GLN PRO GLU TYR ASP LEU GLU SEQRES 29 A 581 LEU ILE THR SER CYS SER SER ASN VAL SER VAL ALA HIS SEQRES 30 A 581 ASP ALA SER GLY LYS ARG VAL TYR TYR LEU THR ARG ASP SEQRES 31 A 581 PRO THR THR PRO LEU ALA ARG ALA ALA TRP GLU THR ALA SEQRES 32 A 581 ARG HIS THR PRO ILE ASN SER TRP LEU GLY ASN ILE ILE SEQRES 33 A 581 MET TYR ALA PRO THR LEU TRP ALA ARG MET ILE LEU MET SEQRES 34 A 581 THR HIS PHE PHE SER ILE LEU LEU ALA GLN GLU GLN LEU SEQRES 35 A 581 GLU LYS ALA LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SEQRES 36 A 581 SER ILE GLU PRO LEU ASP LEU PRO GLN ILE ILE GLU ARG SEQRES 37 A 581 LEU HIS GLY LEU SER ALA PHE THR LEU HIS SER TYR SER SEQRES 38 A 581 PRO GLY GLU ILE ASN ARG VAL ALA SER CYS LEU ARG LYS SEQRES 39 A 581 LEU GLY VAL PRO PRO LEU ARG THR TRP ARG HIS ARG ALA SEQRES 40 A 581 ARG SER VAL ARG ALA LYS LEU LEU SER GLN GLY GLY ARG SEQRES 41 A 581 ALA ALA THR CYS GLY ARG TYR LEU PHE ASN TRP ALA VAL SEQRES 42 A 581 ARG THR LYS LEU LYS LEU THR PRO ILE PRO ALA ALA SER SEQRES 43 A 581 GLN LEU ASP LEU SER GLY TRP PHE VAL ALA GLY TYR SER SEQRES 44 A 581 GLY GLY ASP ILE TYR HIS SER LEU SER ARG ALA ARG PRO SEQRES 45 A 581 ARG LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 581 MET ALA SER SER MET SER TYR THR TRP THR GLY ALA LEU SEQRES 2 B 581 ILE THR PRO CYS ALA ALA GLU GLU SER LYS LEU PRO ILE SEQRES 3 B 581 ASN PRO LEU SER ASN SER LEU LEU ARG HIS HIS ASN MET SEQRES 4 B 581 VAL TYR ALA THR THR SER ARG SER ALA SER LEU ARG GLN SEQRES 5 B 581 LYS LYS VAL THR PHE ASP ARG LEU GLN VAL LEU ASP ASP SEQRES 6 B 581 HIS TYR ARG ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SEQRES 7 B 581 SER THR VAL LYS ALA LYS LEU LEU SER ILE GLU GLU ALA SEQRES 8 B 581 CYS LYS LEU THR PRO PRO HIS SER ALA LYS SER LYS PHE SEQRES 9 B 581 GLY TYR GLY ALA LYS ASP VAL ARG ASN LEU SER SER ARG SEQRES 10 B 581 ALA VAL ASN HIS ILE ARG SER VAL TRP GLU ASP LEU LEU SEQRES 11 B 581 GLU ASP THR GLU THR PRO ILE ASP THR THR ILE MET ALA SEQRES 12 B 581 LYS SER GLU VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY SEQRES 13 B 581 ARG LYS PRO ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY SEQRES 14 B 581 VAL ARG VAL CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SEQRES 15 B 581 SER THR LEU PRO GLN ALA VAL MET GLY SER SER TYR GLY SEQRES 16 B 581 PHE GLN TYR SER PRO LYS GLN ARG VAL GLU PHE LEU VAL SEQRES 17 B 581 ASN THR TRP LYS SER LYS LYS CYS PRO MET GLY PHE SER SEQRES 18 B 581 TYR ASP THR ARG CYS PHE ASP SER THR VAL THR GLU SER SEQRES 19 B 581 ASP ILE ARG VAL GLU GLU SER ILE TYR GLN CYS CYS ASP SEQRES 20 B 581 LEU ALA PRO GLU ALA ARG GLN ALA ILE ARG SER LEU THR SEQRES 21 B 581 GLU ARG LEU TYR ILE GLY GLY PRO LEU THR ASN SER LYS SEQRES 22 B 581 GLY GLN ASN CYS GLY TYR ARG ARG CYS ARG ALA SER GLY SEQRES 23 B 581 VAL LEU THR THR SER CYS GLY ASN THR LEU THR CYS TYR SEQRES 24 B 581 LEU LYS ALA THR ALA ALA CYS ARG ALA ALA LYS LEU GLN SEQRES 25 B 581 ASP CYS THR MET LEU VAL ASN GLY ASP ASP LEU VAL VAL SEQRES 26 B 581 ILE CYS GLU SER ALA GLY THR GLN GLU ASP ALA ALA ALA SEQRES 27 B 581 LEU ARG ALA PHE THR GLU ALA MET THR ARG TYR SER ALA SEQRES 28 B 581 PRO PRO GLY ASP PRO PRO GLN PRO GLU TYR ASP LEU GLU SEQRES 29 B 581 LEU ILE THR SER CYS SER SER ASN VAL SER VAL ALA HIS SEQRES 30 B 581 ASP ALA SER GLY LYS ARG VAL TYR TYR LEU THR ARG ASP SEQRES 31 B 581 PRO THR THR PRO LEU ALA ARG ALA ALA TRP GLU THR ALA SEQRES 32 B 581 ARG HIS THR PRO ILE ASN SER TRP LEU GLY ASN ILE ILE SEQRES 33 B 581 MET TYR ALA PRO THR LEU TRP ALA ARG MET ILE LEU MET SEQRES 34 B 581 THR HIS PHE PHE SER ILE LEU LEU ALA GLN GLU GLN LEU SEQRES 35 B 581 GLU LYS ALA LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SEQRES 36 B 581 SER ILE GLU PRO LEU ASP LEU PRO GLN ILE ILE GLU ARG SEQRES 37 B 581 LEU HIS GLY LEU SER ALA PHE THR LEU HIS SER TYR SER SEQRES 38 B 581 PRO GLY GLU ILE ASN ARG VAL ALA SER CYS LEU ARG LYS SEQRES 39 B 581 LEU GLY VAL PRO PRO LEU ARG THR TRP ARG HIS ARG ALA SEQRES 40 B 581 ARG SER VAL ARG ALA LYS LEU LEU SER GLN GLY GLY ARG SEQRES 41 B 581 ALA ALA THR CYS GLY ARG TYR LEU PHE ASN TRP ALA VAL SEQRES 42 B 581 ARG THR LYS LEU LYS LEU THR PRO ILE PRO ALA ALA SER SEQRES 43 B 581 GLN LEU ASP LEU SER GLY TRP PHE VAL ALA GLY TYR SER SEQRES 44 B 581 GLY GLY ASP ILE TYR HIS SER LEU SER ARG ALA ARG PRO SEQRES 45 B 581 ARG LEU GLU HIS HIS HIS HIS HIS HIS HET XNC A 579 44 HET CL A 580 1 HET CL A 581 1 HET XNC B 579 44 HET CL B 580 1 HETNAM XNC (11S)-11-[4-(BENZYLOXY)-2-FLUOROPHENYL]-3,3-DIMETHYL- HETNAM 2 XNC 10-[(6-METHYLPYRIDIN-2-YL)CARBONYL]-2,3,4,5,10,11- HETNAM 3 XNC HEXAHYDROTHIOPYRANO[3,2-B][1,5]BENZODIAZEPIN-6-OL 1,1- HETNAM 4 XNC DIOXIDE HETNAM CL CHLORIDE ION FORMUL 3 XNC 2(C34 H32 F N3 O5 S) FORMUL 4 CL 3(CL 1-) FORMUL 8 HOH *498(H2 O) HELIX 1 1 ASN A 24 LEU A 31 1 8 HELIX 2 2 HIS A 33 ASN A 35 5 3 HELIX 3 3 THR A 41 ARG A 43 5 3 HELIX 4 4 SER A 44 THR A 53 1 10 HELIX 5 5 ASP A 61 SER A 76 1 16 HELIX 6 6 SER A 84 LEU A 91 1 8 HELIX 7 7 GLY A 104 ASN A 110 1 7 HELIX 8 8 SER A 112 ASP A 129 1 18 HELIX 9 9 ASP A 164 GLY A 188 1 25 HELIX 10 10 SER A 189 TYR A 195 5 7 HELIX 11 11 SER A 196 LYS A 211 1 16 HELIX 12 12 CYS A 223 VAL A 228 1 6 HELIX 13 13 THR A 229 GLN A 241 1 13 HELIX 14 14 ALA A 246 LEU A 260 1 15 HELIX 15 15 THR A 286 ALA A 306 1 21 HELIX 16 16 GLY A 328 TYR A 346 1 19 HELIX 17 17 ASP A 359 LEU A 362 5 4 HELIX 18 18 PRO A 388 ARG A 401 1 14 HELIX 19 19 ASN A 406 TYR A 415 1 10 HELIX 20 20 THR A 418 ILE A 424 1 7 HELIX 21 21 ILE A 424 GLN A 436 1 13 HELIX 22 22 GLU A 455 LEU A 457 5 3 HELIX 23 23 ASP A 458 GLY A 468 1 11 HELIX 24 24 LEU A 469 THR A 473 5 5 HELIX 25 25 SER A 478 GLY A 493 1 16 HELIX 26 26 PRO A 496 GLY A 515 1 20 HELIX 27 27 GLY A 515 PHE A 526 1 12 HELIX 28 28 ASN A 527 VAL A 530 5 4 HELIX 29 29 ILE A 539 LEU A 545 1 7 HELIX 30 30 ASN B 24 LEU B 31 1 8 HELIX 31 31 HIS B 33 ASN B 35 5 3 HELIX 32 32 THR B 41 ARG B 43 5 3 HELIX 33 33 SER B 44 THR B 53 1 10 HELIX 34 34 ASP B 61 SER B 76 1 16 HELIX 35 35 SER B 84 LEU B 91 1 8 HELIX 36 36 GLY B 104 ASN B 110 1 7 HELIX 37 37 SER B 112 ASP B 129 1 18 HELIX 38 38 ASP B 164 GLY B 188 1 25 HELIX 39 39 SER B 189 TYR B 195 5 7 HELIX 40 40 SER B 196 LYS B 211 1 16 HELIX 41 41 CYS B 223 VAL B 228 1 6 HELIX 42 42 THR B 229 GLN B 241 1 13 HELIX 43 43 ALA B 246 LEU B 260 1 15 HELIX 44 44 THR B 286 LYS B 307 1 22 HELIX 45 45 GLY B 328 TYR B 346 1 19 HELIX 46 46 ASP B 359 ILE B 363 5 5 HELIX 47 47 PRO B 388 ARG B 401 1 14 HELIX 48 48 ASN B 406 ALA B 416 1 11 HELIX 49 49 THR B 418 ILE B 424 1 7 HELIX 50 50 ILE B 424 GLU B 437 1 14 HELIX 51 51 GLU B 455 LEU B 457 5 3 HELIX 52 52 ASP B 458 GLY B 468 1 11 HELIX 53 53 LEU B 469 THR B 473 5 5 HELIX 54 54 SER B 478 GLY B 493 1 16 HELIX 55 55 PRO B 496 SER B 513 1 18 HELIX 56 56 GLY B 515 PHE B 526 1 12 HELIX 57 57 ASN B 527 VAL B 530 5 4 HELIX 58 58 ILE B 539 SER B 543 5 5 SHEET 1 A 5 TYR A 4 TRP A 6 0 SHEET 2 A 5 ASN A 273 ARG A 277 -1 O TYR A 276 N THR A 5 SHEET 3 A 5 GLY A 264 THR A 267 -1 N LEU A 266 O CYS A 274 SHEET 4 A 5 THR A 136 ALA A 140 1 N THR A 136 O THR A 267 SHEET 5 A 5 LEU A 159 PHE A 162 -1 O PHE A 162 N THR A 137 SHEET 1 B 2 VAL A 37 ALA A 39 0 SHEET 2 B 2 VAL A 144 CYS A 146 -1 O PHE A 145 N TYR A 38 SHEET 1 C 3 PRO A 214 TYR A 219 0 SHEET 2 C 3 ASP A 319 GLU A 325 -1 O CYS A 324 N MET A 215 SHEET 3 C 3 GLN A 309 ASN A 316 -1 N GLN A 309 O GLU A 325 SHEET 1 D 3 THR A 364 SER A 365 0 SHEET 2 D 3 SER A 368 HIS A 374 -1 O SER A 368 N SER A 365 SHEET 3 D 3 ARG A 380 THR A 385 -1 O VAL A 381 N ALA A 373 SHEET 1 E 3 LEU A 443 ILE A 447 0 SHEET 2 E 3 ALA A 450 ILE A 454 -1 O ILE A 454 N LEU A 443 SHEET 3 E 3 TYR A 561 HIS A 562 1 O HIS A 562 N CYS A 451 SHEET 1 F 5 TYR B 4 TRP B 6 0 SHEET 2 F 5 ASN B 273 ARG B 277 -1 O TYR B 276 N THR B 5 SHEET 3 F 5 GLY B 264 THR B 267 -1 N LEU B 266 O CYS B 274 SHEET 4 F 5 THR B 136 ALA B 140 1 N THR B 136 O THR B 267 SHEET 5 F 5 LEU B 159 PHE B 162 -1 O ILE B 160 N MET B 139 SHEET 1 G 2 VAL B 37 ALA B 39 0 SHEET 2 G 2 VAL B 144 CYS B 146 -1 O PHE B 145 N TYR B 38 SHEET 1 H 3 PRO B 214 TYR B 219 0 SHEET 2 H 3 ASP B 319 GLU B 325 -1 O CYS B 324 N MET B 215 SHEET 3 H 3 GLN B 309 ASN B 316 -1 N THR B 312 O ILE B 323 SHEET 1 I 2 ASN B 369 HIS B 374 0 SHEET 2 I 2 ARG B 380 THR B 385 -1 O VAL B 381 N ALA B 373 SHEET 1 J 3 LEU B 443 ILE B 447 0 SHEET 2 J 3 ALA B 450 ILE B 454 -1 O TYR B 452 N CYS B 445 SHEET 3 J 3 TYR B 561 SER B 563 1 O HIS B 562 N CYS B 451 SHEET 1 K 2 LEU B 545 ASP B 546 0 SHEET 2 K 2 SER B 565 ARG B 566 -1 O SER B 565 N ASP B 546 SITE 1 AC1 19 ARG A 158 PHE A 193 PRO A 197 ARG A 200 SITE 2 AC1 19 CYS A 366 SER A 367 SER A 368 ARG A 386 SITE 3 AC1 19 SER A 407 ASN A 411 MET A 414 TYR A 415 SITE 4 AC1 19 GLN A 446 ILE A 447 TYR A 448 GLY A 449 SITE 5 AC1 19 SER A 556 HOH A 614 HOH A 813 SITE 1 AC2 3 ARG A 501 HIS A 502 ARG A 505 SITE 1 AC3 2 ARG A 394 ASN A 411 SITE 1 AC4 18 PHE B 193 ARG B 200 CYS B 366 SER B 367 SITE 2 AC4 18 SER B 368 ARG B 386 SER B 407 ASN B 411 SITE 3 AC4 18 MET B 414 TYR B 415 GLN B 446 ILE B 447 SITE 4 AC4 18 TYR B 448 GLY B 449 SER B 556 HOH B 670 SITE 5 AC4 18 HOH B 736 HOH B 780 SITE 1 AC5 2 ARG B 394 ASN B 411 CRYST1 106.534 107.573 133.657 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009387 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009296 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007482 0.00000